Rilotumumab, formerly referred to as AMG 102, is a monoclonal antibody primarily utilized as a significant laboratory tool to investigate the mechanisms contributing to neoplastic expansion . This https://lewyswbtv010410.activoblog.com/53647620/rilotumumab-amg-102-a-investigative-instrument-for-studying-growth-development